[1]刘瑞青,申淑景,马杰,等.肺腺癌组织中TTF-1和SPA的表达对EGFR突变的临床预测价值[J].第三军医大学学报,2012,34(22):2314-2317.
　Liu Ruiqing,Shen Shujing,Ma Jie,et al.Clinical value of TTF-1 and SPA expression in predicting EGFR mutations in lung adenocarcinoma[J].J Third Mil Med Univ,2012,34(22):2314-2317.
点击复制

肺腺癌组织中TTF-1和SPA的表达对EGFR突变的临床预测价值(/HTML )
分享到：

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
34卷
期数:
2012年第22期
页码:
2314-2317
栏目:
论著
出版日期:
2012-11-30

文章信息/Info

Title:
Clinical value of TTF-1 and SPA expression in predicting EGFR mutations in lung adenocarcinoma
作者:
刘瑞青; 申淑景; 马杰; 刘杰; 李醒亚
郑州大学第一附属医院：肿瘤科，放疗科；河南省肿瘤医院，郑州大学附属肿瘤医院：病理科，内科
Author(s):
Liu Ruiqing;  Shen Shujing;  Ma Jie;  Liu Jie;  Li Xingya
Department of Oncology, Department of Radiotherapy, First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan Province, 450052; Department of Pathology, Department of Internal Medicine, Henan Province Tumor Hospital, Zhengzhou, Henan Province, 450008, China
关键词:
肺腺癌; 表皮生长因子受体; 甲状腺转录因子; 表面蛋白A
Keywords:
lung adenocarcinoma;  epidermal growth factor receptor;  thyroid transcription factor-1;  surfactant protein-A
分类号:
R394.1；R446.8；R734.2
文献标志码:
A
摘要:
目的      探讨肺腺癌组织中甲状腺转录因子（thyroid transcription factor-1,TTF-1）和表面活性物质A（surfactant protein-A,SPA）的表达对表皮生长因子受体（epidermal growth factor receptor，EGFR）突变状态的临床预测价值。      方法      收集2005年1月至2011年11月在河南省肿瘤医院行EGFR突变检测的肺腺癌患者235例，其中能找到石蜡组织共120例，采用免疫组织化学方法检测组织中的TTF-1和SPA的表达。分析TTF-1和SPA 的表达与EGFR突变状态、临床特征的关系。      结果      入组患者的EGFR突变率为43.8%（103/235）；其中的120例患者中有50例发生EGFR突变； TTF-1阳性表达多见于女性（P=0.029）、不吸烟（P=0.025）和Ⅰ～Ⅱ期（P=0.044）患者；EGFR突变多发生于TTF-1或者SPA（P=0.043）阳性表达患者，TTF-1阴性表达时EGFR很少发生突变（P=0.004），TTF-1对EGFR突变状态的阴性预测价值高达92.6%； TTF-1表达与SPA表达呈显著正相关（r=0.380, P=0.005）。      结论      肺腺癌组织中TTF-1和SPA的表达情况能预测EGFR突变状态，TTF-1或者SPA 阴性表达患者很少发生EGFR突变；TTF-1和SPA的表达具有很好的相关性。
Abstract:
Objective      To explore the clinical value of the expression of thyroid transcription factor-1 (TTF-1) and surfactant protein-A (SPA) in predicting epidermal growth factor receptor (EGFR) mutations in lung adenocarcinoma.       Methods      A total of 235 patients with lung adenocarcinoma who were examined for EGFR mutations from January 2005 to November 2011 in Henan Province Tumor Hospital were enrolled, and 120 patients had paraffin-embedded lung tissue specimens. The expression of TTF-1 and SPA was detected by immunohistochemistry. The correlation of the TTF-1 and SPA expression with EGFR mutations and clinical features in lung adenocarcinoma were analyzed.       Results      There were 103 patients with EGFR mutations in exon 19 or 21 (43.8%, 103/235), and 50 patients with EGFR mutations in the 120 patients. TTF-1 expression was significantly associated with female (P=0.029), non-smokers (P=0.025) and stage Ⅰ-Ⅱ lung adenocarcinoma (P=0.044). EGFR mutation was commonly detected in the patients with TTF-1 or SPA (P=0.043) positive expression, but was rarely found in the patients with TTF-1 negative expression (P=0.004). The negative predictive value of TTF-1 expression for EGFR mutations was 92.6%. TTF-1 expression was correlated with SPA expression (r=0.380, P=0.005).       Conclusion      The expression of TTF-1 and SPA in lung adenocarcinoma helps predict EGFR mutations, and the patients with negative expression of TTF-1 and SPA have few EGFR mutations. The expression of TTF-1 is closely correlated with SPA expression.

参考文献/References:

刘瑞青, 申淑景, 马杰, 等. 肺腺癌组织中TTF-1和SPA的表达对EGFR突变的临床预测价值[J]. 第三军医大学学报,2012,34(22):2314-2317.

相似文献/References:

[1]刘翩,王斌,吴国明.吉非替尼维持治疗晚期肺腺癌长期生存1例[J].第三军医大学学报,2012,34(15):1491.
[2]刁鑫伟,叶明福,谢启超,等.二氢睾酮对前列腺癌LNcap和PC-3细胞株EGFR mRNA表达的影响[J].第三军医大学学报,2005,27(16):1690.
[3]王孟昭,张紫萱.肺癌的靶向治疗[J].第三军医大学学报,2012,34(20):2035.
　Wang Mengzhao,Zhang Zixuan.Target therapy in lung cancer[J].J Third Mil Med Univ,2012,34(22):2035.
[4]杨庆羚,刘翩,王斌,等.EGFR-TKIs治疗晚期非小细胞肺癌并发间质性肺炎4例报告并文献复习[J].第三军医大学学报,2012,34(20):2060.
　Yang Qingling,Liu Pian,Wang Bin,et al.Interstitial pneumonia in EGFR-TKIs-treated non-small-cell lung cancer: report of 4 cases and review of the literature[J].J Third Mil Med Univ,2012,34(22):2060.
[5]刘小军,张雪琳,李莎莎,等.172例肺腺癌脑转移影响因素的临床分析[J].第三军医大学学报,2013,35(01):73.
　Liu Xiaojun,Zhang Xuelin,Li Shasha,et al.Clinical analysis of influencing factors for 172 lung adenocarcinoma patients with brain metastasis[J].J Third Mil Med Univ,2013,35(22):73.
[6]余祖滨,白莉,姚珂,等.SOCS3对肺腺癌细胞株A549迁移和侵袭能力的影响[J].第三军医大学学报,2008,30(07):588.
　YU Zu-bin,BAI Li,YAO Ke,et al.Effects of SOCS3 gene on migration and invasion of lung adenocarcinoma cell line A549[J].J Third Mil Med Univ,2008,30(22):588.
[7]朱冰,杨建茹,付新平,等.GALV致融性糖蛋白转导肺腺癌细胞的抗肿瘤实验研究[J].第三军医大学学报,2007,29(18):1737.
　ZHU Bing,YANG Jian-ru,FU Xin-ping,et al.Antitumor effect of GALV membrane fusion glycoprotein on lung adenocarcinoma in vivo and in vitro[J].J Third Mil Med Univ,2007,29(22):1737.
[8]庞华,罗弋,李少林.人源肺腺癌噬菌体抗体库的构建及初步筛选[J].第三军医大学学报,2008,30(22):2082.
　PANG Hua,LUO Yi,LI Shao-lin.Construction of and screening for phage antibody library of human lung adenocarcinoma[J].J Third Mil Med Univ,2008,30(22):2082.
[9]熊玮,钱桂生,黄桂君.氯氨顺铂诱导耐药后肺腺癌细胞株生物学特性及染色体核型分析[J].第三军医大学学报,2005,27(22):2226.
[10]刁鑫伟,叶明福,张哉根,等.前列腺癌AR表达与细胞增殖的关系[J].第三军医大学学报,2005,27(17):1799.
[11]白莉,祝蓉,陈智鸿,等.靶向EGFR基因的siRNA表达载体构建及其生物学效应的研究[J].第三军医大学学报,2005,27(23):2307.

更新日期/Last Update: 2012-11-20